Marker Therapeutics Inc (MRKR)

[Rkmatters]

I never heard or read that anywhere that they wouldn't raise. I think it is well understood that development stage biotechs that don't earn revenues need to raise to fund clinical trials that if successful will make us all money. That's why the price isn't higher just yet. The way they raise as they move along the development cycle will matter.

I did however read that they have a lot of warrants that can be bought as the stock rises. Is that what you meant? They can't control if their investors exercise those rights or not. If they do, then yes, they won't need to raise capital as much. Not all warrants at companies get exercised. These same financial investors are making similar arrangements across many biotechs. They don't have bottomless pockets to exercise all the warrants available to them IMHO. Time and stock price, and clinical accomplishments and accolades will tell how many of TPIV's get exercised. We have to wait on that. No one knows.

Best,
Rk